Considering Your Treatment Options to Better Manage CML

patientpower has 2382 videos Subscribe Here

Description: With ongoing trials for new drugs like ponatinib and the growing use of dasatinib and nilotinib for CML, patients and their physicians have more options than ever. So how does one decide? In this interview from ASH 2011, Dr. Michael Mauro explains considerations related to changes in therapy; how best to manage side effects and avoid the risk of "running out" of potential drugs. Dr. Mauro stresses, as always, that active dialog, treatment adherance and "lots of information" will help physicians guide their patients to the right treatment strategy.
Shared By : patientpower
Posted on : 03/20/12
Added : 6 years ago
Category : General